Related Experiment Video
Updated: Jul 18, 2026

07:50
Genome-Wide Analysis of DNA Methylation in Gastrointestinal Cancer
Published on: September 18, 2020
Genomic sweeping for hypermethylated genes
Liang Goh1, Susan K Murphy, Sayan Muhkerjee
1Institute for Genome Sciences Policy, Duke University, USA.
Bioinformatics (Oxford, England)
|December 7, 2006
Summary
A new computational method, cluster_boost, identifies novel cancer-associated hypermethylated genes. This approach addresses the challenge of limited known samples and a large number of candidates for cancer biomarker discovery.
Area of Science:
- Genomics
- Cancer Biology
- Bioinformatics
Background:
- Aberrant DNA methylation of CpG islands silences genes, contributing to cancer development.
- Few of the thousands of candidate genes have been validated as hypermethylated in cancer.
- A lack of negative examples (unmethylated genes) hinders novel discovery.
Purpose of the Study:
- To develop a novel computational approach for identifying genes hypermethylated in cancer.
- To address the challenge of imbalanced datasets in cancer gene discovery.
- To discover new potential cancer biomarkers.
Main Methods:
- Developed cluster_boost, a general method for predicting minority class members in imbalanced datasets.
- Utilized genome sequence features to predict candidate hypermethylated genes from a large set of unlabeled genes.
- Validated methylation status for 15 predicted genes in primary ovarian cancers.
Main Results:
- cluster_boost successfully identified minority samples in synthetic datasets mimicking hypermethylated gene data.
- The method predicted novel candidate hypermethylated genes among 14,000 genes.
- Experimental validation confirmed the ability of cluster_boost to identify novel hypermethylated genes in cancer.
Conclusions:
- cluster_boost is an effective computational tool for discovering novel hypermethylated genes in cancer.
- The method facilitates the identification of potential diagnostic and prognostic cancer biomarkers.
- This approach overcomes limitations in existing methods for cancer gene discovery.

